Pharmaceuticals: Scandinavia Industry Guide

  • May 2014
  • -
  • MarketLine
  • -
  • 88 pages

Introduction

The Scandinavian Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The guide also contains descriptions of the leading companies including key financial metrics and analysis of competitive pressures within the market.

Features and benefits

* Save time carrying out entry-level research by identifying the size, growth, and leading players in the Scandinavian pharmaceuticals market.
* Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the Scandinavian pharmaceuticals market.
* Leading company profiles reveal details of key pharmaceuticals market players' Scandinavian operations and financial performance.
* Add weight to presentations and pitches by understanding the future growth prospects of the Scandinavian pharmaceuticals market with forecasts.
* Compares data from Denmark, Norway and Sweden, alongside individual chapters on each country.

Highlights

The Scandinavian pharmaceuticals market had a total market value of $9.7 billion in 2013. Denmark was the fastest growing country with a CAGR of 2.5% over the 2009-13 period.
Within the pharmaceuticals industry, Sweden is the leading country among the Scandinavian countries, with market revenues of $4.5 billion in 2013. This was followed by Denmark and Norway, with $3.0 and $2.1 billion, respectively.
Sweden is expected to lead the pharmaceuticals in the Scandinavian countries, with a value of $5.2 billion in 2018, followed by Denmark and Norway with expected values of $3.6 and $2.2 billion respectively.

Your key questions answered

* What was the size of the Scandinavian pharmaceuticals market by value in 2013?
* What will be the size of the Scandinavian pharmaceuticals market in 2018?
* What factors are affecting the strength of competition in the Scandinavian pharmaceuticals market?
* How has the market performed over the last five years?

Table Of Contents

Pharmaceuticals: Scandinavia Industry Guide
INTRODUCTION
What is this report about?
Who is the target reader?
How to use this report
Definitions
SCANDINAVIA PHARMACEUTICALS
Industry Outlook
PHARMACEUTICALS IN DENMARK
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Leading companies
Macroeconomic indicators
PHARMACEUTICALS IN NORWAY
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Leading companies
Macroeconomic indicators
PHARMACEUTICALS IN SWEDEN
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Leading companies
Macroeconomic indicators
APPENDIX
Methodology

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with ...

OpportunityAnalyzer: Cushing’s Syndrome - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Cushing’s Syndrome - Opportunity Analysis and Forecasts to 2018

  • $ 7 995
  • Industry report
  • January 2015
  • by Global Data

OpportunityAnalyzer: Cushing’s Syndrome - Opportunity Analysis and Forecasts to 2018 Summary GlobalData estimates that the 2013 sales for the Cushing’s syndrome (CS) therapeutic market was approximately ...

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.